Replies to post #191414 on Biotech Values

[DewDiligence]

MNTA sells 8.34M* shares @$19.00—a 6% discount to Monday’s closing price:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-pricing-public-235144962.html

The offering will raise approximately $149M* in net proceeds, giving MNTA a pro forma cash balance of $386M less whatever has been burned since 5/3/15 (#msg-113313146).

MNTA will now have 75.5M* fully-diluted shares for valuation purposes (#msg-113786995).

*Assuming exercise of underwriter’s option.